Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

841
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
841
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

442
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
442

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacy-based triage to preselect high-risk individuals for skin cancer screening: A pilot study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Self-referential processing and emotion regulation in epilepsy: Associations with affective symptom burden.

Epilepsy & behavior : E&B·2026
Same author

[Pigmentary mosaicism: a literature review].

Revue medicale suisse·2026
Same author

Integrative Molecular Analysis of Skin Tumors from Patients with CYLD Cutaneous Syndrome.

The Journal of investigative dermatology·2025
Same author

Author Correction: Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation of Hedgehog signaling in inherited and sporadic basal cell carcinomas.

Nature medicine·2025
Same author

Immune modules to guide diagnosis and personalized treatment of inflammatory skin diseases.

Nature communications·2024
Same journal

M2 Macrophage-Derived ENPP2/LPA Signalling Attenuates UVB-Induced Fibroblast Photoaging via LPAR1/3.

Experimental dermatology·2026
Same journal

Human-Relevant In Vitro Skin Models: From Regulatory-Validated Platforms to Emerging Technologies for Translational Dermatology.

Experimental dermatology·2026
Same journal

Large-Scale Cohort Study on the Genetic and Phenotypic Findings of Palmoplantar Keratodermas in the Chinese Population.

Experimental dermatology·2026
Same journal

52nd Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF).

Experimental dermatology·2026
Same journal

Adverse Event Profile of Apremilast: Pharmacovigilance Study Based on FDA Adverse Event Reporting System (FAERS).

Experimental dermatology·2026
Same journal

Clinical and Immunological Characteristics of Bullous Pemphigoid Patients With Psoriasis Comorbidity: A Retrospective Study.

Experimental dermatology·2026
See all related articles

Related Experiment Video

Updated: Jan 1, 2026

Statistical Methods for Analyzing Epidemiological Data
01:25

Statistical Methods for Analyzing Epidemiological Data

841

Keratoacanthoma: a distinct entity?

Tobias Gleich1, Elena Chiticariu1, Marcel Huber1

  • 1Service of Dermatology, University Hospital Center and University of Lausanne, Lausanne, Switzerland.

Experimental Dermatology
|October 18, 2015
PubMed
Summary
This summary is machine-generated.

Keratoacanthoma (KA) is a distinct benign tumor, not a variant of squamous cell carcinoma (SCC). Its unique molecular signature involves the TGFβ signaling pathway, aiding in diagnosis.

Keywords:
TGF βkeratoacanthomaparadoxical activationsquamous cell carcinomatumor

More Related Videos

Steps in Outbreak Investigation
01:18

Steps in Outbreak Investigation

442

Related Experiment Videos

Last Updated: Jan 1, 2026

Statistical Methods for Analyzing Epidemiological Data
01:25

Statistical Methods for Analyzing Epidemiological Data

841
Steps in Outbreak Investigation
01:18

Steps in Outbreak Investigation

442

Area of Science:

  • Dermatology
  • Oncology
  • Molecular Biology

Background:

  • Keratoacanthoma (KA) are common benign tumors.
  • KA typically appear on sun-exposed skin in fair-skinned individuals.
  • KA exhibit spontaneous resolution.

Purpose of the Study:

  • To review literature on Keratoacanthoma (KA) etiology.
  • To address the debate on KA as a distinct entity versus a variant of squamous cell carcinoma (SCC).
  • To highlight KA's unique molecular signature.

Main Methods:

  • Literature review of existing studies on KA.
  • Analysis of recent findings on KA molecular biology.
  • Comparison of KA and SCC characteristics.

Main Results:

  • KA possesses a unique molecular signature.
  • Alterations in the TGFβ signaling pathway are implicated in KA.
  • KA is proposed as an individual lesion, distinct from SCC.

Conclusions:

  • KA is an individual lesion with a unique molecular profile.
  • TGFβ pathway alterations are key to understanding KA.
  • New diagnostic tools can improve KA and SCC discrimination.